444 related articles for article (PubMed ID: 26122388)
1. Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update.
McCullough KB; Patnaik MM
Curr Hematol Malig Rep; 2015 Sep; 10(3):292-302. PubMed ID: 26122388
[TBL] [Abstract][Full Text] [Related]
2. Chronic Myelomonocytic Leukemia: Focus on Clinical Practice.
Patnaik MM; Tefferi A
Mayo Clin Proc; 2016 Feb; 91(2):259-72. PubMed ID: 26848006
[TBL] [Abstract][Full Text] [Related]
3. Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management.
Patnaik MM; Tefferi A
Am J Hematol; 2016 Jun; 91(6):631-42. PubMed ID: 27185207
[TBL] [Abstract][Full Text] [Related]
4. Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management.
Patnaik MM; Tefferi A
Am J Hematol; 2020 Jan; 95(1):97-115. PubMed ID: 31736132
[TBL] [Abstract][Full Text] [Related]
5. Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.
Patnaik MM; Tefferi A
Am J Hematol; 2018 Jun; 93(6):824-840. PubMed ID: 29878489
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia.
Patnaik MM; Tefferi A
Blood Cancer J; 2016 Feb; 6(2):e393. PubMed ID: 26849014
[TBL] [Abstract][Full Text] [Related]
7. Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management.
Patnaik MM; Tefferi A
Am J Hematol; 2022 Mar; 97(3):352-372. PubMed ID: 34985762
[TBL] [Abstract][Full Text] [Related]
8. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.
Patnaik MM; Tefferi A
Am J Hematol; 2024 Jun; 99(6):1142-1165. PubMed ID: 38450850
[TBL] [Abstract][Full Text] [Related]
9. [Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].
Harada Y; Harada H
Rinsho Ketsueki; 2016 Feb; 57(2):147-55. PubMed ID: 26935632
[TBL] [Abstract][Full Text] [Related]
10. Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.
Parikh SA; Tefferi A
Am J Hematol; 2013 Nov; 88(11):967-74. PubMed ID: 23963888
[TBL] [Abstract][Full Text] [Related]
11. Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review.
Patnaik MM; Parikh SA; Hanson CA; Tefferi A
Br J Haematol; 2014 May; 165(3):273-86. PubMed ID: 24467717
[TBL] [Abstract][Full Text] [Related]
12. Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies.
Padron E; Steensma DP
Curr Opin Hematol; 2015 Mar; 22(2):163-70. PubMed ID: 25575034
[TBL] [Abstract][Full Text] [Related]
13. Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
Patnaik MM; Tefferi A
Am J Hematol; 2023 Apr; 98(4):681-689. PubMed ID: 36601682
[TBL] [Abstract][Full Text] [Related]
14. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis.
Hu Z; Hu S; Ji C; Tang Z; Thakral B; Loghavi S; Medeiros LJ; Wang W
Leuk Res; 2018 Feb; 65():25-28. PubMed ID: 29288910
[TBL] [Abstract][Full Text] [Related]
15. Mutations in chronic myelomonocytic leukemia and their prognostic relevance.
Jian J; Qiao Y; Li Y; Guo Y; Ma H; Liu B
Clin Transl Oncol; 2021 Sep; 23(9):1731-1742. PubMed ID: 33861431
[TBL] [Abstract][Full Text] [Related]
16. Current management of patients with chronic myelomonocytic leukemia.
Alfonso A; Montalban-Bravo G; Garcia-Manero G
Curr Opin Oncol; 2017 Jan; 29(1):79-87. PubMed ID: 27849645
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review.
Patnaik MM; Lasho T
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):460-464. PubMed ID: 33275673
[TBL] [Abstract][Full Text] [Related]
18. Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.
Palomo L; Garcia O; Arnan M; Xicoy B; Fuster F; Cabezón M; Coll R; Ademà V; Grau J; Jiménez MJ; Pomares H; Marcé S; Mallo M; Millá F; Alonso E; Sureda A; Gallardo D; Feliu E; Ribera JM; Solé F; Zamora L
Oncotarget; 2016 Aug; 7(35):57021-57035. PubMed ID: 27486981
[TBL] [Abstract][Full Text] [Related]
19. Chronic myelomonocytic leukemia diagnosis and management.
Chan O; Renneville A; Padron E
Leukemia; 2021 Jun; 35(6):1552-1562. PubMed ID: 33714974
[TBL] [Abstract][Full Text] [Related]
20. Chronic Myelomonocytic Leukemia: 2018 Update to Prognosis and Treatment.
Elmariah H; DeZern AE
Curr Hematol Malig Rep; 2019 Jun; 14(3):154-163. PubMed ID: 31093889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
